EMBC.US Embecta Corp

Healthcare Health Care Equipment & Supplies USA Stocks
6.46 USD
Close of Nov 14, 2026
2.76 14.33
Market cap
USD 366M
P/E
4.4x
P/B
2.61x
ROE
-
Dividend yield
9.56%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is EMBC.US undervalued?

Graham number
Price6.46
Graham value9.04
Discount28.6%

EMBC.US trades 28.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Embecta Corp fundamental analysis

No fundamental analysis for Embecta Corp yet.

Embecta Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Embecta Corp

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded …

Full company profile